Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · IEX Real-Time Price · USD
281.02
-9.84 (-3.38%)
Apr 18, 2024, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 403.82 | 434.22 | 470.78 | 662.21 | 660.67 | 431.53 | 383.82 | 456.26 | 457.55 | 413.25 | Upgrade
|
| Short-Term Investments | 1,209 | 1,362 | 404.7 | 334.47 | 459.53 | 418.83 | 376.71 | 387.74 | 332.93 | 284.38 | Upgrade
|
| Cash & Cash Equivalents | 1,613 | 1,796 | 875.48 | 996.68 | 1,120 | 850.36 | 760.54 | 844 | 790.48 | 697.64 | Upgrade
|
| Cash Growth | -10.22% | 105.17% | -12.16% | -11.03% | 31.73% | 11.81% | -9.89% | 6.77% | 13.31% | 14.57% | Upgrade
|
| Receivables | 489.02 | 494.65 | 423.54 | 419.42 | 392.67 | 392.44 | 464.85 | 372.35 | 391.49 | 377.64 | Upgrade
|
| Inventory | 780.52 | 719.32 | 572.24 | 622.25 | 554.01 | 583.82 | 594.8 | 524.96 | 490.22 | 471 | Upgrade
|
| Other Current Assets | 166.09 | 147.78 | 119.23 | 101.48 | 113.27 | 196.86 | 156.46 | 103.22 | 105.41 | 170.1 | Upgrade
|
| Total Current Assets | 3,048 | 3,158 | 1,990 | 2,140 | 2,180 | 2,023 | 1,977 | 1,845 | 1,778 | 1,716 | Upgrade
|
| Property, Plant & Equipment | 723.74 | 679.56 | 716.44 | 693.51 | 701.21 | 508.69 | 493.5 | 488.61 | 437.69 | 428.84 | Upgrade
|
| Long-Term Investments | 7,698 | 8,831 | 14,387 | 9,561 | 4,638 | 2,656 | 1,028 | 830.79 | 719.84 | 389.31 | Upgrade
|
| Goodwill and Intangibles | 734.08 | 738.64 | 601.28 | 491.41 | 409.66 | 352.89 | 680.18 | 638.72 | 709.97 | 754.67 | Upgrade
|
| Other Long-Term Assets | 94.85 | 94.6 | 104.19 | 86.72 | 79.64 | 70.3 | 94.95 | 47.85 | 64.62 | 52.1 | Upgrade
|
| Total Long-Term Assets | 9,251 | 10,344 | 15,809 | 10,833 | 5,829 | 3,588 | 2,296 | 2,006 | 1,932 | 1,625 | Upgrade
|
| Total Assets | 12,299 | 13,502 | 17,799 | 12,973 | 8,009 | 5,611 | 4,273 | 3,851 | 3,710 | 3,341 | Upgrade
|
| Accounts Payable | 144.63 | 135.04 | 141.94 | 139.45 | 107.01 | 122.45 | 135.18 | 133.11 | 122.39 | 128.61 | Upgrade
|
| Deferred Revenue | 0 | 0 | 50.85 | 42.47 | 33.74 | 26.94 | 28.23 | 31 | 29.68 | 26.72 | Upgrade
|
| Current Debt | 40.87 | 36.8 | 36.92 | 38.31 | 461.54 | 0.49 | 0.42 | 0.33 | 0.3 | 0.27 | Upgrade
|
| Other Current Liabilities | 337.31 | 396.87 | 451.22 | 411.31 | 303.21 | 300.92 | 338.86 | 306.88 | 288.98 | 291.17 | Upgrade
|
| Total Current Liabilities | 522.8 | 568.71 | 680.94 | 631.54 | 905.5 | 450.8 | 502.7 | 471.32 | 441.35 | 446.76 | Upgrade
|
| Long-Term Debt | 1,365 | 1,351 | 186.45 | 187.39 | 189.6 | 438.94 | 434.58 | 434.19 | 433.88 | 435.71 | Upgrade
|
| Other Long-Term Liabilities | 1,671 | 1,966 | 3,247 | 2,274 | 1,159 | 701.01 | 405.49 | 365.84 | 343.98 | 273.65 | Upgrade
|
| Total Long-Term Liabilities | 3,035 | 3,318 | 3,433 | 2,461 | 1,348 | 1,140 | 840.07 | 800.02 | 777.86 | 709.36 | Upgrade
|
| Total Liabilities | 3,558 | 3,886 | 4,114 | 3,093 | 2,254 | 1,591 | 1,343 | 1,271 | 1,219 | 1,156 | Upgrade
|
| Total Debt | 1,405 | 1,388 | 223.38 | 225.69 | 651.13 | 439.43 | 435 | 434.52 | 434.18 | 435.98 | Upgrade
|
| Debt Growth | 1.24% | 521.42% | -1.03% | -65.34% | 48.18% | 1.02% | 0.11% | 0.08% | -0.41% | -0.33% | Upgrade
|
| Retained Earnings | 9,261 | 9,898 | 13,525 | 9,268 | 5,471 | 3,722 | 1,830 | 1,829 | 1,808 | 1,695 | Upgrade
|
| Comprehensive Income | -336.04 | -466.82 | -175.55 | 282.46 | -87.35 | -46.96 | 738.79 | 417.77 | 382.14 | 218.95 | Upgrade
|
| Shareholders' Equity | 8,741 | 9,615 | 13,685 | 9,880 | 5,755 | 4,020 | 2,930 | 2,579 | 2,491 | 2,185 | Upgrade
|
| Net Cash / Debt | 207.31 | 408.12 | 652.1 | 770.99 | 469.07 | 410.93 | 325.54 | 409.48 | 356.3 | 261.66 | Upgrade
|
| Net Cash / Debt Growth | -49.20% | -37.42% | -15.42% | 64.36% | 14.15% | 26.23% | -20.50% | 14.93% | 36.17% | 52.55% | Upgrade
|
| Net Cash Per Share | 7.10 | 13.70 | 21.59 | 25.56 | 15.54 | 13.59 | 10.84 | 13.81 | 12.12 | 8.98 | Upgrade
|
| Working Capital | 2,526 | 2,589 | 1,310 | 1,508 | 1,275 | 1,573 | 1,474 | 1,373 | 1,336 | 1,270 | Upgrade
|
| Book Value Per Share | 299.26 | 322.82 | 458.76 | 331.90 | 192.84 | 134.75 | 98.81 | 87.61 | 85.33 | 75.67 | Upgrade
|